Dr John Campbell shows for 50-59 year olds – prevent one hospitalization, cause 54 adverse events. The UK’s JCVI knew this and DENIED INFORMED CONSENT

From here:

Numbers needed to vaccinate data - YouTube

Number needed to vaccinate (NNV) = 43,600 50-59 year olds to prevent one “non-serious” hospitalization –

NNV for “serious” hospitalization NNV = 256,400 50–59 year olds to prevent a serious hospitalization

Using analysis (source in the YouTube video) of the combined Pfizer/BioNTech and Moderna Phase 3 clinical trials for C19 mRNA vaccinations – results showed adverse events = one vaxx adverse event per 800 people vaccinated.

Age stratification of the clinical trials has been (criminally) withheld so closer analysis is not possible.

Let’s do some ball-park arithmetic.

Vaxx 43,500 50–59-year-olds to prevent one hospitalization – adverse events of special interest (AESI) caused = 43,500/800 = 54 AESI (and change) to prevent one (non-serious) hospitalization.

Vaxx 256,400 50-59 year olds – AESI = 266,400/800 = 333 AESI to prevent one serious hospitalization

Dr Campbell shows other numbers and stresses the point that since the Omicron variant is much milder than original and delta strains, the risk/benefit analysis has changed completely. (Personally I believe it was never a benefit, even for (especially for) the vulnerable).

Here is a representation of the Pfizer/BioNTech Phase 3 clinical trial results (4 months of results considered by the FDA for trials terminated at the end of November 2020, that were started at the end of July 2020 and were supposed to run for six months until the end of January 2021).

The COVID-19 Inoculations - More Harm Than Good FINAL Video & Print (canadiancovidcarealliance.org)

21,900 or so in each of the injected and the placebo groups. Note the “Related Adverse Events” in the placebo group are extraordinarily high at 1,311 per 21,900 – suggesting that the injections for the placebo group were the same as the injected group – except for the mRNA component.

We need to correlate terms here – how “severe” and “serious“ are the Phase 3 clinical trial  AESI’s compared to the definitions used in the UK hospitalizations (for non-serious and serios hospitalizations).

It is usual to define “serious” as life threatening and “severe” as life altering – though whether this is the same as “serious” and “non-serious” hospitalizations is not clear. Neither is the significance of “severe” impacts suffered in homes (outside hospitals) in the UK data. Are these just 1% of all “severe” cases, or do 99% of “severe” cases make it to hospital (and then can be compared directly to “severe” events in the Phase 3 clinical trials).

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) had this information on 25 October 2022 the JCVI has done nothing with this data to provide INFORMED CONSENT to the British public.

Onwards!

I drink a lot of coffee – if you like my “stuff” but don’t want to pay for a subscription (that pays for food and internet!) buy me a cup to show (any!) appreciation here: https://ko-fi.com/peterhalligan